FDA Clearance Tracker · K170416
LZI Methadone Metabolite Enzyme Immunoassay, LZI Methadone Metabolite (100 and 300) Calibrators
Last checked: Nov 20, 2026Latest source record: Jun 26, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Jun 26, 2017
Substantially Equivalent
Time to decision
136 days
Received Feb 10, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K170416
- Device name
- LZI Methadone Metabolite Enzyme Immunoassay, LZI Methadone Metabolite (100 and 300) Calibrators
- Applicant
- Lin-Zhi International, Inc.
- Applicant location
- Santa Clara, CA
- Received
- Feb 10, 2017
- Decided
- Jun 26, 2017
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Enzyme Immunoassay, Methadone (DJR)
- Device class
- Class II
- Regulation
- 21 CFR 862.3620
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DJR. The earliest in FDA's data is K840060, decided Mar 19, 1984.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K170416
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Lin-Zhi International, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253082 · Decided Jan 16, 2026 · 115 days after receipt
Device type: Enzyme Immunoassay, Opiates (DJG) · Laboratory Medicine & Pathology
K251634 · Decided Jun 18, 2025 · 20 days after receipt
Device type: Enzyme Immunoassay, Opiates (DJG) · Laboratory Medicine & Pathology
K202007 · Decided Sep 17, 2020 · 58 days after receipt
Device type: Enzyme Immunoassay, Opiates (DJG) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.